• 1
    Centers for Disease Control and Prevention. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: recommendations of the Panel on Clinical Practices for treatment of HIV. MMWR. 2002;51(RR-7):810.
  • 2
    Weinstein MC, Goldie SJ, Losina E, et al. Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness. Ann Intern Med. 2001;134: 44050.
  • 3
    Henry K. The case for more cautious, patient-focused antiretroviral therapy. Ann Intern Med. 2000;132: 30611.
  • 4
    Anderson L. Health care communication and selected psychological adherence in diabetes management. Diabetes Care. 1990;13: 667.
  • 5
    Rost K. The influence of patient participation on satisfaction and compliance. Diabetes Educ. 1989;15: 1348.
  • 6
    Street R, Piziak V, Carpentier W, Herzog J, Hejl J. Provider-patient communication and metabolic control. Diabetes Care. 1993;16: 71421.
  • 7
    Kaplan SM, Greenfield S, Ware J. Assessing the effects of physician–patient interaction on the outcomes of chronic disease. Med Care. 1989;27: 11027.
  • 8
    Stewart M. What is a successful doctor-patient interview? A study of interactions and outcomes. Soc Sci Med. 1984;19: 16775.
  • 9
    Rost K, Carter WI. Introduction of information during the initial medical visit: consequences for patient follow-through with physician recommendations for medication. Soc Sci Med. 1989;28: 31521.
  • 10
    Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients’ participation in medical care: Effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3: 44857.
  • 11
    Korsch B, Gozzi E, Francis V. Gaps in doctor-patient communication: Doctor–patient interaction and patient satisfaction. Pediatrics. 1968;42: 85571.
  • 12
    Roter D, Hall J. Doctors Talking with Patients/Patients Talking with Doctors. Westport, Conn: Auburn House; 1993.
  • 13
    Murphy D, Murphy DA, Roberts KJ, Martin DJ, Marelich W, Hoffman D. Barriers to antiretroviral adherence among HIV-Infected adults. AIDS Patient Care STDs. 2000;14: 4758.
  • 14
    Golin CE, Isasi F, Breny Bontempi J, Eng G. Secret pills: HIV-positive patients’ experiences taking antiretroviral therapy in North Carolina, submitted AIDS Education Prevention.
  • 15
    Sleath B, Roter D, Chewning B, Svarstad B. Asking questions about medication: analysis of physician–patient interactions and physician perceptions. Med Care. 1999;37: 116973.
  • 16
    Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care. 1988;6: 65775.
  • 17
    Gordillo V, Del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13: 17639.
  • 18
    Paterson L, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133: 2130.
  • 19
    Golin CE, Kaplan A, Liu HH, et al. Patient Factors Associated with and Self-reported Reasons for Nonadherence to Antiretroviral Therapy. Society for General Internal Medicine 22nd Annual Meeting, San Francisco, May 1, 1999.
  • 20
    Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19: 12433.
  • 21
    Chesney M, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence Instruments. AIDS Care. 2000;12: 25566.
  • 22
    Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14: 26773.
  • 23
    Laws MB, Wilson RB, Bowser DM, Kerr S. Taking antiretroviral therapy for HIV infection: learning from patients’ stories. J Gen Intern Med. 2000;15: 84858.
  • 24
    Gifford A, Bormann J, Shively M, et al. Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000; 23: 38695.
  • 25
    Meystre-Agustoni G, Dubois-Arber F, Cochand P, Telenti A. Antiretroviral therapies from the patient's perspective. AIDS Care. 2000;12: 71721.
  • 26
    Turner B, Newschaffer C, Zhang D, Cosler L, Hauck W. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV infected women. Med Care. 2000;38: 91125.
  • 27
    Kitahata MM, Koepsell TD, Deyo RA, et al. Physicians’ experience with the acquired immunodeficiency syndrome as a factor in patients’ survival. N Engl J Med. 1996;334: 7016.
  • 28
    Kitihata MM, Van Rompaey SE, Shields AW. Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. JAIDS. 2000;24: 10614.
  • 29
    Hecht FM, Wilson IB, Wu AW, Cook RL, Turner BJ. Optimizing care for persons with HIV infection. Ann Intern Med. 1999;131: 13643.
  • 30
    Markson LE, Turner BJ, Crocroft J, Houchens R, Fanning TR. Clinic services for persons with AIDS. Experience in a high-prevalence state. J Gen Intern Med. 1997;12: 1419.
  • 31
    Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med. 2001; 16: 3608.
  • 32
    Bach PB, Calhoun EA, Bennett CL. Identifying providers of care to individuals with human immunodeficiency virus for a mail survey using a prescription tracking database. J Clin Epidemiol. 1999;52: 14750.
  • 33
    United States Pharmacopeial Convention. USP Medication Counseling Behavior Guidelines, USP DI Update Vols I and II, 66475.
  • 34
    Healthcare Solutionseries Level 3. Arlington, Va: Claritas, Inc; 2000.
  • 35
    Department of Health and Human Services. Area Resource File 2000 Washington (DC): Office of Research and Planning Bureau of Health Professions Health Resources and Services Administration. Washington, DC: Department of Health and Human Services; February 2000.
  • 36
    Linzer M, Konrad TR, Douglas J, et al. Managed care, time pressure, and physician job satisfaction: results from the physician worklife study. J Gen Intern Med. 2000;15: 44150.
  • 37
    Katz MD, Draugalis JR, Lai RP. HIV infection, AIDS: attitudes and knowledge of Arizona pharmacists. Ann Pharmacother. 1995;29: 121823.
  • 38
    Jones AM. Health econometrics. In: CulyerAJ, NewhouseJP, eds. Handbook of Health Economics. Amsterdam: North Holland; 2000: 265344.
  • 39
    Liao TF Interpreting Probability Models. Logit, Probit, and Other Generalized Linear Models: Sage University Paper Series, Quantitative Applications in the Social Sciences #101. Thousand Oaks, Calif.: Sage Publications; 1994.
  • 40
    Allison PD. Poisson regression. In: Logistic Regression: Using the SAS System Theory and Application. 2235.
  • 41
    Campion EW. A symptom of discontent. N Engl J Med. 2001;334: 2235.
  • 42
    Mechanic D. How should hamsters run? Some observations about sufficient patient time in primary care. BMJ. 2001;323: 2668.
  • 43
    Druss BG, Marcus SC, Olfson M, et al. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood). 2001;20: 23341.
  • 44
    Knight M, Stewart-Brown S, Fletcher L. Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys. J Public Health Med. 2001; 23: 17986.
  • 45
    Geiss LS, Herman WH, Goldschmid MG, et al. Surveillance for diabetes mellitus – United States, 1980–89. CDC Surveillance Summaries. Morb Mortal Wkly Rep. 1993;42: 120.
  • 46
    Collins JG. Prevalence of selected chronic conditions: United States, 1990–92. Vital & Health Statistics – Series 10. Data from the National Health Survey. 1997;194:189.
  • 47
    Bluespruce J, Dodge WT, Grothaus L, et al. HIV prevention in primary care: impact of a clinical intervention. AIDS Patient Care STDs. 2001;15: 24353.
  • 48
    Yeager KK, Donehoo RS, Macera CA, et al. Health promotion practices among physicians. Am J Prev Med. 1996;12: 23841.
  • 49
    Gill JM. Physician performance of preventive care for women. Del Med J. 1996;68: 34955.
  • 50
    Marvel MK, Schilling R, Doherty WJ, Baird MA. Levels of physician involvement with patients and their families: a model for teaching and research. J Fam Pract. 1994;39: 53544.
  • 51
    CDC Semiannual HIV/AIDS Surveillance Report, 2001.
  • 52
    Freedberg KA, Losina E, Weinstein MC, et al. The cost-effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001;344: 82431.
  • 53
    Bozette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344: 81723.
  • 54
    Miller LG, Liu HH, Hays RD, et al. How well do clinicians estimate patients’ adherence to combination antiretroviral therapy? J Gen Intern Med. 2002;17: 111.
  • 55
    Armour BS, Pitts MM, Maclean R, et al. The effect of explicit financial incentives on physician behavior. Arch Intern Med. 2001;161: 12616.
  • 56
    Tufano J, Conrad DA, Sales A, et al. Effects of compensation method on physician behaviors. Am J Manag Care. 2001;7: 36373.
  • 57
    Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003; 36: 5148.
  • 58
    Smith SS, Reif S, Golin C. Collaborations between case managers and pharmacists in HIV/AIDS care. APHA 129th Annual Meeting, Atlanta, Ga., October 21–25, 2001.
  • 59
    Holmes WC. Quality in HIV/AIDS care: Specialty-related or experience-related? J Gen Intern Med. 1997;12: 1957.
  • 60
    Landon B, Wilson I, Wenger N, et al. Specialty training and specialization among physicians who treat HIV/AIDS in the United States. J Gen Intern Med. 2002;17: 1222.
  • 61
    Epstein RM, Levenkron JC, Frarey L, et al. Improving physicians’ HIV risk-assessment skills using announced and unannounced standardized patients. J Gen Intern Med. 2001;16: 17680.
  • 62
    Brandon W. Changing treatment regimens for HIV infection: impact on referral patterns and training needs of family physicians. J Am Board Fam Pract. 1999;12: 1159.
  • 63
    Carpenter CCJ, Cooper DA, Fischl MA, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society—USA Panel. JAMA. 2000;283: 38190.